RegenMed Webinar: Michael P. Tierney, CEO and Co-Founder, Discusses The Company’s Investment Theses

December 6, 2024

Share This Page
View as PDF

RegenMed Webinar: Michael P. Tierney, CEO and Co-Founder, Discusses The Company’s Investment Theses

December 6, 2024

RegenMed is an established, revenue-producing company disrupting a + $1 trillion healthcare data market.

Our November 12 webinar discussed the foundational elements which have led to its global client base, strong monthly recurring revenue growth, competitive moats, and plans for accelerated market capture.

A total of ten self-contained segments from that webinar can be viewed on the Company’s Investors Page.  The first three can be viewed below.  The remainder will be published in subsequent Campaign Updates.

THE FOUNDING OF A “ZERO-TO- ONE” COMPANY
REAL WORLD HEALTHCARE DATA: THE RAW MATERIAL OF A + $1 TRILLION MARKET
THE VALUABLE FINAL PRODUCT: REAL-WORLD EVIDENCE

Invest today in a company with a proven product market fit, growing recurring revenues, competitive moats, and seasoned leadership which is disrupting a + $1 trillion market.

INVEST NOW
Share This Page

RegenMed Webinar: Michael P. Tierney, CEO and Co-Founder, Discusses The Company’s Investment Theses

December 6, 2024

RegenMed is an established, revenue-producing company disrupting a + $1 trillion healthcare data market.

Our November 12 webinar discussed the foundational elements which have led to its global client base, strong monthly recurring revenue growth, competitive moats, and plans for accelerated market capture.

A total of ten self-contained segments from that webinar can be viewed on the Company’s Investors Page.  The first three can be viewed below.  The remainder will be published in subsequent Campaign Updates.

THE FOUNDING OF A “ZERO-TO- ONE” COMPANY
REAL WORLD HEALTHCARE DATA: THE RAW MATERIAL OF A + $1 TRILLION MARKET
THE VALUABLE FINAL PRODUCT: REAL-WORLD EVIDENCE

Invest today in a company with a proven product market fit, growing recurring revenues, competitive moats, and seasoned leadership which is disrupting a + $1 trillion market.

INVEST NOW

This Reg CF offering is made available through StartEngine Primary, LLC.  This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.

‍

Share This Page

Read The Latest

December 18, 2024

Are You A Shockwave Practitioner? Improve and Monetize Your Patient Outcomes Through Physicians-Owned Circles

The fast-growing shockwave market is already valued at $3 billion. Manufacturers around the world are investing in new devices and applicators to address the rising demand for non-surgical therapeutic options. They need clinical evidence to support those new technologies...

December 12, 2024

RegenMed Investment Theses Webinar Recording Now Available

On November 12, RegenMed’s CEO and Co-Founder Michael P. Tierney conducted a webinar discussing the Company’s investment theses and global traction. The webinar recording has been divided into ten chapters, now available on the Company’s Investors Page.

December 10, 2024

Live-streamed Investors Webinar "Expectations 2025"

Please join us for RegenMed, Inc. Investors Webinar, Monday, December 16 at 6:30 PM, New York time. RegenMed's CEO Michael P Tierney will review the Company's momentum through the end of the year, as well as expectations for 2025.